 
 On Thursday, the Food and Drug Administration approved Journavx, a highly anticipated non-opioid pain medication developed by Vertex Pharmaceuticals, marking a significant milestone in the effort to shift pain treatment away from opioids. This new drug has been initially approved to treat acute
 
 The current landscape of behavioral health startups is marked by a competitive funding environment. Companies in this sector face numerous challenges as they strive to secure capital, navigate investment trends, and differentiate themselves in a crowded market. This article explores these dynamics,
 
 Teladoc Health, a prominent player in the telehealth market, has been navigating a challenging financial landscape while striving to maintain its expansive reach and drive future growth. With 93 million members and 10,000 customers, the company has a significant presence in the virtual healthcare
 
 The global digital health industry is on the brink of a remarkable growth trajectory, with its market value expected to surge from USD 8,131.3 million in 2024 to USD 16,603.7 million by 2034. This substantial rise represents a compound annual growth rate (CAGR) of 7.4% over the forecast period,
 
 Mexico is at the forefront of a digital health revolution, particularly in the realm of Electronic Health Records (EHR). This rapid transformation is driven by a combination of government initiatives, regulatory changes, and a growing demand for modernized healthcare systems. The country’s
 
 MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of